Caerphilly study finds no link between homocysteine and CHD
Main Authors: | Lyford Joanna, Fallon UB, Ben-Shlomo Y, Elwood P, Ubbink JB, Davey Smith G |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2001-02-01
|
Series: | Current Controlled Trials in Cardiovascular Medicine |
Subjects: | |
Online Access: | http://cvm.controlled-trials.com/paperreport/cvm-2001-72106 |
Similar Items
-
Homocysteine Level According to Some Cardiac Risk Factors and Extent of Coronary Disease
by: Sepideh Sokhanvar, et al.
Published: (2011-04-01) -
Algorithm of Differentiated Approach to the Treatment of CHD Patients with Impaired Homocysteine and Vitamin D Metabolism before and after Coronary Artery Bypass Grafting
by: O. S. Nikonenko, et al.
Published: (2020-05-01) -
Sortilin and Homocysteine as Potential Biomarkers for Coronary Artery Diseases
by: Werida RH, et al.
Published: (2021-09-01) -
Homocysteine, Β Vitamins and Immune Activation in Coronary Heart Disease
by: Frick Barbara, et al.
Published: (2003-08-01) -
Effect of Homocysteine on the Cardiac Function and Coronary Flow in the Isolated Heart of Rat
by: Daryoosh Shackebaei, et al.
Published: (2007-09-01)